Target intelligence / Profile preview

SH3 and PX domain-containing protein 2B (SH3PXD2B)

Target
SH3PXD2B
Molecular classification
Other (Adaptor/Scaffold protein)
01

Overview

SH3 and PX domain-containing protein 2B (SH3PXD2B), also known as TKS4, is an adaptor protein characterized by one PX domain and four SH3 (Src homology 3) domains[1][2][3][4][5]. It is crucial for the formation and function of podosomes and invadopodia—specialized, actin-rich membrane structures that mediate cell adhesion, cell migration, and extracellular matrix (ECM) degradation[1][2][3][4][5]. SH3PXD2B serves as a scaffold, recruiting proteins such as matrix metalloproteinases (MMPs), ADAM metalloproteases, and components of the NADPH oxidase (NOX) complex to the membrane, facilitating processes like ECM remodeling and regulated ROS production[1][4]. SH3PXD2B is required for normal embryonic development in tissues such as bone, heart, and eye. Mutations in this protein cause severe multisystem congenital syndromes, including Frank-ter Haar syndrome (FTHS) and Borrone dermato-cardio-skeletal syndrome (BDCS), both characterized by skeletal, craniofacial, cardiovascular, and ocular abnormalities[1][2]. While not a classical drug target such as a receptor, enzyme, or transporter, its role in cell invasion and ECM remodeling suggests potential relevance to cancer metastasis[4].

Other names
FAD49KIAA1295TKS4FLJ20831Adapter protein HOFIFactor for adipocyte differentiation 49Tyrosine kinase substrate with four SH3 domainsFTHSHOFITSK4
02

Biological functions

Cell adhesionCell migrationPodosome and invadopodia formationExtracellular matrix remodelingReactive oxygen species (ROS) regulationAdipocyte differentiation
03

Disease associations

Congenital syndromes (Frank-ter Haar syndrome, Borrone dermato-cardio-skeletal syndrome)Skeletal dysplasiaCardiac defectsPotential roles in cancer cell invasion and metastasis
04

Safety considerations

Loss-of-function causes severe congenital disorders (Frank-ter Haar syndrome, BDCS)Essential for normal development of bone, heart, and other tissues

Beyond the preview

Go deeper on SH3 and PX domain-containing protein 2B (SH3PXD2B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SH3 and PX domain-containing protein 2B (SH3PXD2B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call